Early-Onset Trends and Collaborative Solutions
What Is Driving the Increase?
Various ideas have been put forth concerning why some cancers are increasing in younger people. Diet, obesity, alcohol, antibiotics, microplastics, environmental conditions and genetic mutations are often mentioned.4 However, no definitive cause has been established. The growing range of theories emphasizes the urgent need for increased efforts to discover what is causing this disturbing trend.
Biopharma and Community Oncology: Key Collaborators In the Search for Answers
Biopharma and community oncology have critical roles to play in determining what is behind the rise in cancers in younger people. The NIH analysis concluded future studies must investigate trends in early-onset cancers across a wide range of demographics and geography.1 Community oncology is perfectly positioned to do that, as community practices treat more than half of all cancer patients in the U.S.5 With practices serving large volumes of a variety of patient populations from rural areas to metropolitan centers, their patients reflect real-world populations.
Biopharma can collaborate with community practices to access electronic health record data, enabling analysis of treatment patterns, mutation prevalence and outcomes in younger versus older patients. These insights can inform clinical trial design, particularly if unique mutations, trends or treatment responses are identified. Once trials are launched, practices can efficiently recruit appropriate patients from their heterogeneous patient populations.
Unique Needs of Younger Patients
Patients battling early-onset cancer face unique challenges, making their needs distinct. They typically juggle work and childcare responsibilities in addition to treatment. Severe emotional distress is common as they face uncertainty about their future and the welfare of their young family. While many have good insurance, maintaining coverage can become problematic if illness affects their ability to work. Early involvement of social workers is recommended, as they can offer counseling and additional support mechanisms to help with job-related issues, insurance matters and funding assistance.
In this digital age, younger patients are seeking connection and reassurance beyond the clinic walls. Many turn to online peer support groups to share experiences and find encouragement from others facing similar challenges. Expanding these resources — and ensuring they are tailored to the realities of younger adults — can make a meaningful difference in helping patients navigate the emotional and logistical disruptions that come with an early cancer diagnosis.
Implications for Patient Management
Caring for younger patients requires a different approach as well. For instance, genetic testing is critical, as treatment options like precision medicine therapies depend on genetic findings.
Sexual health, relationship issues and fertility preservation are also significant concerns for younger patients. Practical barriers, such as insurance coverage and treatment delays, often complicate the situation. Unfortunately, insurance coverage for freezing eggs, embryos or sperm is inconsistent and often inadequate. Medicaid coverage is dependent on the state as there is no federal mandate, making it important for patients to verify their coverage.
link
